Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Massari, Francesco
Item TypeName
Academic Article Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.
Academic Article Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma.
Academic Article Immune checkpoint inhibitors for metastatic bladder cancer.
Academic Article Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution.
Academic Article The prospect of precision therapy for renal cell carcinoma.
Academic Article Emerging Immunotargets and Immunotherapies in Prostate Cancer.
Academic Article BAP1 in solid tumors.
Academic Article Prostate cancer heterogeneity: Discovering novel molecular targets for therapy.
Academic Article Immunotargeting and personalized therapies in genitourinary cancers.
Academic Article Present and future of personalized medicine in adult genitourinary tumors.
Academic Article Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
Academic Article BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Academic Article Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.
Academic Article Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.
Academic Article Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
Academic Article Emerging Immunotargets in Metastatic Renal Cell Carcinoma.
Academic Article Bladder cancer: molecular determinants of personalized therapy.
Academic Article The immunocheckpoints in modern oncology: the next 15 years.
Academic Article Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma.
Academic Article Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort.
Academic Article Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
Academic Article Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies.
Academic Article New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials.
Academic Article Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.
Academic Article Tp53 and its potential therapeutic role as a target in bladder cancer.
Academic Article An update on investigational therapies that target STAT3 for the treatment of cancer.
Academic Article Treating Prostate Cancer by Antibody-Drug Conjugates.
Academic Article Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC?risk groups in metastatic renal cell carcinoma: a meta-analysis.
Concept Molecular Targeted Therapy
Search Criteria
  • Molecular Targeted Therapy